Woo, Jonghak; Kim, Eungdo; Sung, Tae-Eung; Lee, Jongtaik; … - In: Journal of open innovation : technology, market, and … 5 (2019) 3/45, pp. 1-19
The financial valuation of a drug that is still under development is required for various purposes. The risk-adjusted net present value (r-NPV) method, which recently emerged in the biotech industry, uses the development attrition rate as a discount factor to reflect risk during each development...
